• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨桥蛋白在肝癌中的过度表达及其与肿瘤细胞转移、侵袭的关系。

Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells.

机构信息

Department of Hepatobiliary Surgery, First Municipal People's Hospital of Guangzhou, The Affiliated Hospital of Guangzhou Medical College, Guangzhou 510180, People's Republic of China.

出版信息

Mol Biol Rep. 2011 Nov;38(8):5205-10. doi: 10.1007/s11033-010-0671-4. Epub 2010 Dec 29.

DOI:10.1007/s11033-010-0671-4
PMID:21188534
Abstract

Osteopontin (OPN) plays an important role in metastasis and relapse of human cancer. However, the whole story of OPN relating to cancer has been far from clear untill now. To investigate the expression of OPN in hepatocellular carcinoma (HCC) and its relationships with recurrence and metastasis of HCC, normal and malignant liver tissues from patients with HCC were analyzed using immunohistochemical staining. OPN expression was inhibited by small interfering RNA (siRNA) in HCC cells lines, and then colony formation and matrigel invasion were examined. The results showed that expression of OPN was associated with metastasis of HCC with a positive rate of OPN in the tissue of HCC (70.00%), which was highly more obvious than those in paracarcinoma tissue and normal liver tissue (P < 0.01). In HCC cell lines, OPN depletion could reduce formed colony and metastasizing numbers in vitro. In conclusion, Expression of OPN in the tissue of HCC is related to metastasis or metastases. Specific siRNA could decrease expressions of OPN at both mRNA and protein levels, and abates the invasiveness of hepatocellular carcinoma cells, suggesting that OPN might be a promising agent for treatment of metastasis and recurrence of HCC.

摘要

骨桥蛋白(OPN)在人类癌症的转移和复发中起着重要作用。然而,直到现在,OPN 与癌症相关的全部情况还远未清楚。为了研究骨桥蛋白在肝细胞癌(HCC)中的表达及其与 HCC 复发和转移的关系,采用免疫组织化学染色分析了 HCC 患者的正常和恶性肝组织中的 OPN 表达。用小干扰 RNA(siRNA)抑制 HCC 细胞系中的 OPN 表达,然后检查集落形成和基质胶侵袭。结果表明,OPN 的表达与 HCC 的转移有关,HCC 组织中 OPN 的阳性率(70.00%)明显高于癌旁组织和正常肝组织(P<0.01)。在 HCC 细胞系中,OPN 耗竭可减少体外形成的集落和转移数量。总之,HCC 组织中 OPN 的表达与转移或转移有关。特异性 siRNA 可降低 OPN 在 mRNA 和蛋白质水平的表达,并减弱肝癌细胞的侵袭性,提示 OPN 可能是治疗 HCC 转移和复发的有前途的药物。

相似文献

1
Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells.骨桥蛋白在肝癌中的过度表达及其与肿瘤细胞转移、侵袭的关系。
Mol Biol Rep. 2011 Nov;38(8):5205-10. doi: 10.1007/s11033-010-0671-4. Epub 2010 Dec 29.
2
[Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].骨桥蛋白表达的干扰抑制人肝癌细胞系的侵袭和转移
Zhonghua Gan Zang Bing Za Zhi. 2009 Jun;17(6):422-5.
3
[Knocking down osteopontin expression by specific siRNA reduces the in vitro invasiveness of human hepatocellular carcinoma cells].通过特异性小干扰RNA敲低骨桥蛋白表达可降低人肝癌细胞的体外侵袭能力
Zhonghua Zhong Liu Za Zhi. 2006 Jun;28(6):404-7.
4
C-C chemokine receptor type 1 mediates osteopontin-promoted metastasis in hepatocellular carcinoma.C-C趋化因子受体1介导骨桥蛋白促进的肝癌转移。
Cancer Sci. 2018 Mar;109(3):710-723. doi: 10.1111/cas.13487. Epub 2018 Feb 13.
5
Segment-specific targeting via RNA interference mediates down-regulation of OPN expression in hepatocellular carcinoma cells.通过RNA干扰进行的特定片段靶向介导了肝癌细胞中骨桥蛋白(OPN)表达的下调。
Genet Mol Res. 2015 Nov 19;14(4):14440-7. doi: 10.4238/2015.November.18.6.
6
Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression.骨桥蛋白通过上调 MMP-2 和 uPA 的表达促进肝癌侵袭。
Mol Biol Rep. 2011 Aug;38(6):3671-7. doi: 10.1007/s11033-010-0481-8. Epub 2010 Nov 23.
7
Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma.骨桥蛋白通过上调 DNMT1 改变 DNA 甲基化,使肝癌中 CD133+/CD44+ 肿瘤干细胞对 5-氮杂胞苷敏感。
J Exp Clin Cancer Res. 2018 Jul 31;37(1):179. doi: 10.1186/s13046-018-0832-1.
8
Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.30千道尔顿的Tat相互作用蛋白通过抑制人肝细胞癌中骨桥蛋白的转录来抑制肿瘤转移。
Hepatology. 2008 Jul;48(1):265-75. doi: 10.1002/hep.22280.
9
Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH.Array-CGH 检测到与骨桥蛋白表达相关的肝细胞癌中的基因组异常。
J Cancer Res Clin Oncol. 2010 Apr;136(4):595-601. doi: 10.1007/s00432-009-0695-0. Epub 2009 Oct 16.
10
Correlation and prognostic value of osteopontin and Bcl-2 in hepatocellular carcinoma patients after curative resection.骨桥蛋白和 Bcl-2 在肝癌患者根治性切除术后的相关性及其预后价值。
Oncol Rep. 2013 Dec;30(6):2795-803. doi: 10.3892/or.2013.2737. Epub 2013 Sep 19.

引用本文的文献

1
SPP1 is a prognostic related biomarker and correlated with tumor-infiltrating immune cells in ovarian cancer.SPP1 是一种与卵巢癌肿瘤浸润免疫细胞相关的预后相关生物标志物。
BMC Cancer. 2022 Dec 30;22(1):1367. doi: 10.1186/s12885-022-10485-8.
2
MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells.微小RNA作为乳腺肿瘤细胞中多柔比星耐药性的关键调节因子。
Cancer Cell Int. 2021 Apr 15;21(1):213. doi: 10.1186/s12935-021-01873-4.
3
Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation.骨桥蛋白:肿瘤进展与免疫调节的关键调节因子

本文引用的文献

1
Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression.骨桥蛋白通过上调 MMP-2 和 uPA 的表达促进肝癌侵袭。
Mol Biol Rep. 2011 Aug;38(6):3671-7. doi: 10.1007/s11033-010-0481-8. Epub 2010 Nov 23.
2
Hepatic blood inflow occlusion with/without hemihepatic artery control versus the Pringle maneuver in resection of hepatocellular carcinoma: a retrospective comparative analysis.肝血流阻断联合/不联合半肝动脉阻断与肝门阻断法在肝细胞癌切除术中的应用:一项回顾性对比分析。
Chin Med J (Engl). 2010 Jun;123(11):1413-6.
3
The osteopontin gene +1239A/C single nucleotide polymorphism is associated with type 1 diabetes mellitus in the Italian population.
Cancers (Basel). 2020 Nov 15;12(11):3379. doi: 10.3390/cancers12113379.
4
Sorafenib Treatment and Modulation of the Sphingolipid Pathway Affect Proliferation and Viability of Hepatocellular Carcinoma In Vitro.索拉非尼治疗及对鞘脂代谢通路的调控对体外肝癌细胞增殖和活力的影响。
Int J Mol Sci. 2020 Mar 31;21(7):2409. doi: 10.3390/ijms21072409.
5
Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies.使用嵌合抗原受体和双特异性抗体的肝细胞癌免疫疗法。
Cancer Lett. 2017 Jul 28;399:44-52. doi: 10.1016/j.canlet.2017.04.013. Epub 2017 Apr 17.
6
NF‑κB inhibition is associated with OPN/MMP‑9 downregulation in cutaneous melanoma.NF-κB抑制与皮肤黑色素瘤中骨桥蛋白/基质金属蛋白酶-9的下调有关。
Oncol Rep. 2017 Feb;37(2):737-746. doi: 10.3892/or.2017.5362. Epub 2017 Jan 10.
7
A preliminary in vivo study of the effects of OPN on rat liver regeneration induced by partial hepatectomy.骨桥蛋白对部分肝切除诱导的大鼠肝再生影响的初步体内研究。
Mol Biol Rep. 2016 Dec;43(12):1371-1382. doi: 10.1007/s11033-016-4071-2. Epub 2016 Sep 1.
8
Osteopontin regulates proliferation, apoptosis, and migration of murine claudin-low mammary tumor cells.骨桥蛋白调节小鼠claudin低表达乳腺肿瘤细胞的增殖、凋亡和迁移。
BMC Cancer. 2016 Jun 10;16:359. doi: 10.1186/s12885-016-2396-9.
9
Higher Matrix Stiffness Upregulates Osteopontin Expression in Hepatocellular Carcinoma Cells Mediated by Integrin β1/GSK3β/β-Catenin Signaling Pathway.更高的基质硬度通过整合素β1/GSK3β/β-连环蛋白信号通路介导上调肝癌细胞中骨桥蛋白的表达。
PLoS One. 2015 Aug 17;10(8):e0134243. doi: 10.1371/journal.pone.0134243. eCollection 2015.
10
Glycosylation and liver cancer.糖基化与肝癌
Adv Cancer Res. 2015;126:257-79. doi: 10.1016/bs.acr.2014.11.005. Epub 2015 Feb 7.
骨桥蛋白基因+1239A/C 单核苷酸多态性与意大利人群 1 型糖尿病有关。
Int J Immunopathol Pharmacol. 2010 Jan-Mar;23(1):263-9. doi: 10.1177/039463201002300124.
4
Osteopontin expression in pulmonary tumor thrombotic microangiopathy caused by gastric carcinoma.骨桥蛋白在胃癌所致肺肿瘤血栓性微血管病中的表达
Pathol Int. 2009 Oct;59(10):752-6. doi: 10.1111/j.1440-1827.2009.02439.x.
5
Response of cementoblast-like cells to mechanical tensile or compressive stress at physiological levels in vitro.体外生理水平下成牙骨质细胞样细胞对机械拉伸或压缩应力的反应。
Mol Biol Rep. 2009 Sep;36(7):1741-8. doi: 10.1007/s11033-008-9376-3. Epub 2008 Oct 11.
6
Introduction of G1 phase arrest in Human Hepatocellular carcinoma cells (HHCC) by APMCF1 gene transfection through the down-regulation of TIMP3 and up-regulation of the CDK inhibitors p21.通过下调TIMP3和上调细胞周期蛋白依赖性激酶抑制剂p21,利用APMCF1基因转染在人肝癌细胞(HHCC)中诱导G1期阻滞。
Mol Biol Rep. 2006 Dec;33(4):257-63. doi: 10.1007/s11033-006-9007-9. Epub 2006 Nov 2.
7
An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo.一种针对骨桥蛋白的可诱导短发夹RNA载体可降低人食管鳞状细胞癌在体外和体内的转移潜能。
Clin Cancer Res. 2006 Feb 15;12(4):1308-16. doi: 10.1158/1078-0432.CCR-05-1611.
8
Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer.S100A4和骨桥蛋白与微创乳腺癌患者特定预后因素及生存的相关性
Clin Cancer Res. 2006 Feb 15;12(4):1192-200. doi: 10.1158/1078-0432.CCR-05-1580.
9
Osteopontin: role in cell signaling and cancer progression.骨桥蛋白:在细胞信号传导和癌症进展中的作用。
Trends Cell Biol. 2006 Feb;16(2):79-87. doi: 10.1016/j.tcb.2005.12.005. Epub 2006 Jan 10.
10
Use of RNA interference to inhibit integrin subunit alphaV-mediated angiogenesis.利用RNA干扰抑制整合素αV亚基介导的血管生成。
Angiogenesis. 2005;8(4):361-72. doi: 10.1007/s10456-005-9026-5. Epub 2006 Jan 7.